Horizontal Ridge Reconstruction of Atrophic Anterior Maxillary Ridges Using Customized Xenograft Bone Shell With 1 :1 Mixture of Autogenous and Xenograft Bone Particulate
NCT ID: NCT04075942
Last Updated: 2021-01-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
8 participants
INTERVENTIONAL
2021-01-31
2021-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Autogenous Tooth Graft for Ridge Augmentation
NCT06416605
Autogenous Grafts for Anterior Maxillary Horizontal Ridge Augmentation
NCT06206577
Artificial Intelligence-Enhanced Three-Dimensional Reconstruction of Ridge Deficiencies
NCT06693921
Cortical Bone Plate Versus Cortico-cancellous Block Graft
NCT04567966
Guided Bone Regeneration in Atrophic Anterior Maxillary Ridges
NCT03731416
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All surgical procedures were performed under strict aseptic conditions, all patients received infiltration local anesthesia (Articaine 4% 1:100 000 epinephrine).
a midcrestal incision was made in the anterior region using No. 15 blade. A full thickness mucoperiosteal flap was raised to expose the underlying alveolar ridge. The residual remaining bone in the area was minimal, with a maximum measured ridge thickness of 3 or 4 mm. 'To reconstruct the lost alveolar bone, an xenograft bone shell approximately 1 to 2 mm thick was shaped, after 3D print the bone shell were fixed to the buccal defect, using screws . 'The space between the plate and the existing palatal bone wall was then filled using a combination of autograft bone chips and xenograft bone particles
. Periosteal releasing incision is done to obtain stress free primary closure. The flap will then be closed using interrupted 4/0 resorbable sutures. After 4 month will insert implant . After 3 month will insert final restoration which will be mostly PMF .
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Atrophic Anterior Maxillary Ridges participants
Using customized Xenograft bone shell with equal mixture of autogenous and xenograft particulate bone as a graft with the modified cortical shell technique, with atrophic anterior maxilla with less than 5 mm Bucco-lingual
Atrophic Anterior Maxillary Ridges
Use of modified cortical shell technique grafted with customized Xenograft bone shell
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Atrophic Anterior Maxillary Ridges
Use of modified cortical shell technique grafted with customized Xenograft bone shell
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Uncontrolled diabetic patients.
* Pregnant patients. Psychiatric patient
* pathology related to bone.
15 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Manal Ahmed Hassan Ahmed
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Manal Ahmed Hassan Ahmed
Faculty of dentistry, Master degree of dental Implantology
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PER 6-3-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.